levodopa has been researched along with Cholera Infantum in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (27.78) | 18.7374 |
| 1990's | 5 (13.89) | 18.2507 |
| 2000's | 8 (22.22) | 29.6817 |
| 2010's | 10 (27.78) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Pilipovich, AA; Vorob'eva, OV | 1 |
| Baróti, B; Constantin, V; Forró, T; Kelemen, K; Mihály, I; Nagy, E; Orbán-Kis, K; Rácz, A; Szász, J; Szatmári, S; Török, I | 1 |
| Lolekha, P; Sriphanom, T; Vilaichone, RK | 1 |
| Arakawa, M; Hokari, M; Ishikawa, A; Kondo, T; Mezaki, N; Miura, T; Nishizawa, M; Ozawa, T; Sakai, N; Takeshima, A; Takeuchi, R; Tokunaga, J; Utsumi, K; Yokoseki, A | 1 |
| Doi, H; Hirai, S; Kishi, M; Sakakibara, R; Tateno, F; Tsuyuzaki, Y | 1 |
| Carpintero, P; de Deus, T; de la Fuente-Fernandez, R; Echarri-Piudo, A; Llaneza-Gonzalez, MA; Lopez-Pazos, E; Macias-Arribi, M; Santos-Garcia, D | 1 |
| Anguera-Vila, A; Calle-Pardo, A; Carriedo-Ule, D; Diez-Liebana, MJ; Fernandez-Martinez, MN; Garcia-Vieitez, JJ; Hernandez-Echevarria, L; Sahagún-Prieto, AM; Sierra-Vega, M | 1 |
| Altmann, V; Callegari-Jacques, SM; Hutz, MH; Rieck, M; Rieder, CRM; Schumacher-Schuh, AF | 1 |
| Fung, VS; Herawati, L; Wan, Y | 1 |
| Calle, AP; Diez, MJ; Fernández, N; García, JJ; Sahagún, A; Sierra, M | 1 |
| Araki, H; Inuzuka, T; Kato, T; Moriwaki, H; Murase, M; Nagaki, M; Nishida, H; Tanaka, Y | 1 |
| Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY | 1 |
| Stiefelhagen, P | 1 |
| Albani, G; Cattaldo, S; De Gennaro, M; El Assawy, N; Gregorini, F; Mauro, A; Pradotto, L | 1 |
| Budzianowska, A; Gołab-Janowska, M; Honczarenko, K | 1 |
| Bömelburg, M; Ebersbach, G; Jugel, C; Klostermann, F; Marzinzik, F; Müller, T | 1 |
| Barichella, M; Caccialanza, R; Cancello, R; Cassani, E; Cereda, E; Iorio, L; Madio, C; Pezzoli, G; Pusani, C | 1 |
| Foster, HD; Hoffer, A | 1 |
| Marinus, J; Schipper, RGB; Stiggelbout, AM; van Hilten, JJ; Visser, M | 1 |
| Onofrj, M; Thomas, A | 1 |
| Weiner, M | 1 |
| Matthews, D; Mawdsley, C; Pentland, B | 1 |
| Yanagisawa, N | 1 |
| Aitken, JW; Fotteler, B; Jorga, KM; Nielsen, T; Sedek, G; Zürcher, G | 1 |
| McCallum, RW; Sarosiek, I; Shifflett, J; Soykan, I; Wooten, GF | 1 |
| Barrett, RE; Cote, LJ; Fahn, S; Isgreen, WP; Lesser, RP; Snider, SR | 1 |
| Bianchine, JR; Shaw, GM | 1 |
| Piccirilli, M; Quartesan, R | 1 |
| Girke, W; Xenakis, Ch | 1 |
| Vladyka, V | 1 |
| Pfeiffer, R | 1 |
| Fischer, GJ; Quandt, J; Sommer, H | 1 |
| Ferrari, E | 1 |
| Steinhäusl, H | 1 |
7 review(s) available for levodopa and Cholera Infantum
| Article | Year |
|---|---|
[Gastrointestinal dysfunction has important implications for plasma L-dopa concentrations in Parkinson's disease].
Topics: Antiparkinson Agents; Autonomic Nervous System Diseases; Drug Tolerance; Drugs, Chinese Herbal; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease; Phytotherapy | 2013 |
[Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease].
Topics: Antiparkinson Agents; Carbidopa; Double-Blind Method; Drug Therapy, Combination; Duodenum; Gastrointestinal Diseases; Gastrostomy; Granuloma; Humans; Infusion Pumps; Infusions, Parenteral; Levodopa; Multicenter Studies as Topic; Observational Studies as Topic; Pain; Parkinson Disease; Peritonitis; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; Surgical Stomas | 2014 |
Update on antiparkinsonian agents.
Topics: Aged; Amantadine; Antiparkinson Agents; Blood-Brain Barrier; Bromocriptine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Histamine H1 Antagonists; Humans; Levodopa; Parasympatholytics; Parkinson Disease; Receptors, Dopamine; Selegiline; Vascular Resistance | 1982 |
[Guidelines of drug therapies for Parkinson's disease].
Topics: Anxiety; Cholinergic Antagonists; Dopamine Agonists; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Parkinson Disease; Practice Guidelines as Topic; Quality of Life; Urination Disorders | 1997 |
Clinical pharmacokinetics of levodopa in parkinson's disease.
Topics: Carboxy-Lyases; Cardiovascular Diseases; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gastric Mucosa; Gastrointestinal Diseases; Homovanillic Acid; Humans; Intestinal Absorption; Kinetics; Levodopa; Mental Disorders; Parkinson Disease; Pyridoxine; Stimulation, Chemical; Time Factors | 1976 |
[Side-effects of L-dopa therapy].
Topics: Arrhythmias, Cardiac; Basal Ganglia Diseases; Depression; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Male; Nausea; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Sex Factors; Time Factors; Vomiting | 1975 |
Optimization of levodopa therapy.
Topics: Antiparkinson Agents; Carbidopa; Dose-Response Relationship, Drug; Drug Interactions; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Levodopa; Mental Disorders; Sleep Wake Disorders | 1992 |
6 trial(s) available for levodopa and Cholera Infantum
| Article | Year |
|---|---|
A randomised clinical trial to evaluate the effects of Plantago ovata husk in Parkinson patients: changes in levodopa pharmacokinetics and biochemical parameters.
Topics: Aged; Animals; Cholesterol, LDL; Dietary Fiber; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Plantago; Seeds; Triglycerides | 2014 |
Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone.
Topics: Aged; Antiparkinson Agents; Benserazide; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catechols; Double-Blind Method; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Nitriles; Parkinson Disease; Quality of Life; Severity of Illness Index; Treatment Outcome | 2009 |
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly.
Topics: Administration, Oral; Aged; Analysis of Variance; Antiparkinson Agents; Benzophenones; Catechol O-Methyltransferase Inhibitors; Dopamine Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Enzyme Inhibitors; Erythrocytes; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Nervous System Diseases; Nitrophenols; Tolcapone | 1997 |
An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial. HP-200 in Parkinson's Disease Study Group.
Topics: Administration, Oral; Antiparkinson Agents; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Medicine, Ayurvedic; Middle Aged; Parkinson Disease; Plant Extracts; Severity of Illness Index | 1995 |
Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Bromocriptine; Carbidopa; Domperidone; Dopamine Antagonists; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Selegiline; Severity of Illness Index | 1997 |
[Experiences in the treatment of Parkinson's disease with a combination drug: L-dopa plus decarboxylase inhibitor (Ro 8-0576)].
Topics: Benserazide; Carboxy-Lyases; Clinical Trials as Topic; Dihydroxyphenylalanine; Drug Combinations; Evaluation Studies as Topic; Gastrointestinal Diseases; Gymnastics; Humans; Hydrazines; Levodopa; Parkinson Disease; Speech Therapy | 1973 |
23 other study(ies) available for levodopa and Cholera Infantum
| Article | Year |
|---|---|
[Upper gastrointestinal tract dysfunction and its correction by dopamine agonists for patients with Parkinson's disease of I-III stage].
Topics: Adult; Aged; Aged, 80 and over; Deglutition Disorders; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Piribedil; Quality of Life; Sialorrhea; Upper Gastrointestinal Tract | 2022 |
The importance of evaluation of gastrointestinal symptoms in advanced Parkinson’s disease
Topics: Antiparkinson Agents; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease | 2020 |
Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial).
Topics: Aged; Anti-Bacterial Agents; Antiparkinson Agents; Breath Tests; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Quality of Life | 2021 |
Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients.
Topics: Aged; Antiparkinson Agents; Autonomic Nervous System Diseases; Female; Gastrointestinal Diseases; Ghrelin; Hormones; Humans; Levodopa; Male; Multiple System Atrophy | 2013 |
Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.
Topics: Aged; Female; Gastrointestinal Diseases; Genetic Predisposition to Disease; Genotype; Humans; Levodopa; Male; Parkinson Disease; Polymorphism, Genetic; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2018 |
Effects of Plantago ovata husk on levodopa (with Carbidopa) bioavailability in rabbits with autonomic gastrointestinal disorders.
Topics: Animals; Autonomic Nervous System; Biological Availability; Carbidopa; Gastrointestinal Diseases; Levodopa; Plantago; Rabbits | 2009 |
Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the 13C-acetate breath test.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon Isotopes; Dopamine Agents; Dyskinesias; Female; Gastric Emptying; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2009 |
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome | 2009 |
[Dysphagia, constipation, impacted feces: Parkinson disease is also a gastrointestinal disease].
Topics: Antiparkinson Agents; Constipation; Deglutition Disorders; Fecal Impaction; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease | 2010 |
Electrogastrographyc activity in Parkinson's disease patients with and without motor fluctuations.
Topics: Aged; Antiparkinson Agents; Electrophysiology; Female; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Random Allocation | 2011 |
[Autonomic disorders in Parkinson's disease].
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Causality; Comorbidity; Constipation; Deglutition Disorders; Erectile Dysfunction; Female; Gastrointestinal Diseases; Humans; Hypotension, Orthostatic; Incidence; Levodopa; Male; Middle Aged; Nocturia; Parkinson Disease; Severity of Illness Index; Sex Distribution; Sialorrhea; Statistics, Nonparametric; Urinary Incontinence; Urologic Diseases; Vomiting | 2011 |
Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion.
Topics: Aged; Antiparkinson Agents; Carbidopa; Drug Combinations; Female; Gastrointestinal Diseases; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Parkinson Disease | 2012 |
Nutritional risk and gastrointestinal dysautonomia symptoms in Parkinson's disease outpatients hospitalised on a scheduled basis.
Topics: Aged; Confidence Intervals; Constipation; Deglutition Disorders; Female; Gastrointestinal Diseases; Hospitalization; Humans; Levodopa; Male; Malnutrition; Middle Aged; Nutritional Status; Odds Ratio; Outpatients; Parkinson Disease; Prevalence; Primary Dysautonomias; Risk Factors; Severity of Illness Index; Sialorrhea; Weight Loss | 2013 |
The two faces of L-DOPA: benefits and adverse side effects in the treatment of Encephalitis lethargica, Parkinson's disease, multiple sclerosis and amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Antioxidants; Antiparkinson Agents; Dopamine Agents; Dyskinesia, Drug-Induced; Gastrointestinal Diseases; Hallucinations; Humans; Levodopa; Multiple Sclerosis; Oxidative Stress; Parkinson Disease; Parkinson Disease, Postencephalitic; Psychoses, Substance-Induced; Sleep Initiation and Maintenance Disorders; Vitamin B Complex | 2004 |
Assessing comorbidity in patients with Parkinson's disease.
Topics: Activities of Daily Living; Aged; Antiparkinson Agents; Cognition Disorders; Comorbidity; Disability Evaluation; Gastrointestinal Diseases; Humans; Levodopa; Male; Male Urogenital Diseases; Neuropsychological Tests; Parkinson Disease; Primary Health Care; Surveys and Questionnaires | 2004 |
Acute akinesia in Parkinson disease.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Akinetic Mutism; Apomorphine; Body Temperature; Cohort Studies; Comorbidity; Dopamine Agents; Dose-Response Relationship, Drug; Drug Resistance; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Mortality; Neuroleptic Malignant Syndrome; Parkinson Disease; Prospective Studies; Recovery of Function; Treatment Failure | 2005 |
Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect.
Topics: Antiparkinson Agents; Bromocriptine; Carbidopa; Catechols; Clinical Trials as Topic; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Dyskinesias; France; Gastrointestinal Diseases; Humans; Levodopa; Parkinson Disease | 2005 |
Parkinson's disease: long-term results of levodopa therapy.
Topics: Adult; Aged; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Substance-Related Disorders | 1982 |
Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy.
Topics: Adolescent; Adult; Aged; Chorea; Encephalitis; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Time Factors | 1979 |
[Review of problems in the treatment of the parkinsonian syndrome with L-dopa].
Topics: Arrhythmias, Cardiac; Cardiovascular Diseases; Gastrointestinal Diseases; Humans; Hypertension; Hypotension, Orthostatic; Levodopa; Movement Disorders; Parkinson Disease, Secondary; Psychoses, Substance-Induced | 1976 |
[Side effects in the treatment with L-dopa].
Topics: Chemical and Drug Induced Liver Injury; Female; Gastrointestinal Diseases; Humans; Hyperkinesis; Levodopa; Male; Middle Aged; Parkinson Disease | 1975 |
[The problem of side effects after a treatment with L-dopa in the Parkinson's syndrome: clinical and animal studies (author's transl)].
Topics: Adult; Aged; Brain; Cardiovascular Diseases; Dopamine; Drug Eruptions; Female; Gastrointestinal Diseases; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Pain; Paresthesia; Parkinson Disease, Secondary; Psychoses, Substance-Induced | 1974 |
[Problems in the administration of L-DOPA (author's transl)].
Topics: Cardiovascular Diseases; Drug Eruptions; Gastrointestinal Diseases; Humans; Levodopa; Mental Disorders; Movement Disorders; Parkinson Disease; Urologic Diseases; Vision Disorders | 1974 |